Nadmed (private company)
See something wrong or missing? Let us know
Offices:Helsinki
Industry:BiotechHealth services
Business model:B2B
Nadmed is a biotech startup in Finland developing a proprietary nicotinamide adenine dinucleotide (NAD) measurement technology that may help clinicians establish more precise and personalized treatments for various diseases.
Investors:
we tracked 3 investors
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
values in USD
Investments 3.8M
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Companies with similar profile to Nadmed
Name | Criteria | |
---|---|---|
![]() |
APIM Therapeutics
53%
|
|
![]() |
FinnAdvance
53%
|
|
![]() |
iLoF
53%
|
|
![]() |
Novai
53%
|
|
![]() |
SonoClear
53%
|
|
![]() |
ViveBiotech
53%
|
|
![]() |
CellulaREvolution
53%
|
|
![]() |
ActiTrexx
53%
|
|
![]() |
ResoTher Pharma
53%
|
|
![]() |
SmartCatch
53%
|
|